Investor Relations

SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and

... More »

pdf SciClone Corporate Presentation September 2014.

pdf China Regulatory and Commercialization Backgrounder

Recent Releases

Oct 30, 2014
SciClone Pharmaceuticals to Report Financial Results for the Third Quarter 2014 on November 10th

Sep 17, 2014
SciClone to Present at BioCentury NewsMakers in the Biotech Industry Conference on September 26, 2014

View all releases »

Events & Presentations

Nov 10, 2014 at 4:30 PM ET
Q3 2014 SciClone Pharmaceuticals, Inc. Earnings

Sep 26, 2014 at 11:30 AM ET
2014 BioCentury NewsMakers in the Biotech Industry Conference

View all events & presentations »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
SciClone Pharmaceuticals, Inc.
Price: 7.89
Change: - 0.04
Day High: 8.02
Day Low: 7.77
Volume: 639,900
Delayed at least 20 minutes.
Provided by eSignal.